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Abstract  
The gamma-herpesvirus alcelaphine herpesvirus-1 (AlHV-1) causes fatal malignant catarrhal fever 
(MCF) in susceptible species including cattle, but infects its reservoir host, wildebeest, without 
disease.   Pathology in cattle may be influenced by virus-host cell interactions mediated by the virus 
glycoproteins. Cloning and expression of a haemagglutinin-tagged version of the AlHV-1 
glycoprotein B (gB) was used to demonstrate that the AlHV-1-specific monoclonal antibody 12B5 
recognised gB and that gB was the main component of the gp115 complex of AlHV-1, a glycoprotein 
complex of five components identified on the surface of AlHV-1 by immunoprecipitation and 
radiolabelling. Analysis of AlHV-1 virus particles showed that the native form of gB was detected by 
mAb 12B5 as a band of about 70kDa, whilst recombinant gB expressed by transfected HEK293T 
cells appeared to be subject to additional cleavage and incomplete post-translational processing.  
Antibody 12B5 recognised an epitope on the N-terminal furin-cleaved fragment of gB on AlHV-1 
virus particles. It could be used to detect recombinant and virus-expressed gB on western blots and on 
the cell-surface of infected cells by flow cytometry, whilst recombinant gB was detected at the surface 
of transfected cells by immunofluorescence. Recombinant gB has potential as an antigen for ELISA 
detection of MCF virus infection and as a candidate vaccine antigen. 
 
Keywords: malignant catarrhal fever; herpesvirus; macavirus; glycoprotein B; fusion tag; mammalian 
expression; monoclonal antibody 
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Introduction 
Malignant catarrhal fever (MCF) is a fatal lymphoproliferative disease of cattle, deer, bison and other 
ungulates, caused by ruminant gammaherpesviruses of the genus Macavirus 
1
.  Alcelaphine 
herpesvirus 1 (AlHV-1), which is among the best studied of the MCF viruses, naturally infects 
wildebeest, causing MCF among in-contact cattle in sub-Saharan Africa. The other major cause of 
MCF worldwide is ovine herpesvirus 2 (OvHV-2), which naturally infects domestic sheep 
2
. The 
MCF viruses infect their natural hosts without obvious clinical signs, causing a lifelong, latent 
infection. In the wildebeest, AlHV-1 cell-free virus appears to be shed in nasal secretions and other 
body fluids during occasional recrudescence of lytic infection in adults, but the major source of 
infectious virus appears to be wildebeest calves that shed virus for a prolonged period during their 
first few months of life.  This virus presents a major infectious disease challenge for in-contact cattle, 
and Massai herdsmen move their cattle to poorer upland grazing to avoid wildebeest during the 
calving season 
3, 4
.  
MCF in cattle is a dramatic, fatal lymphoproliferative disease characterized by lymphocyte 
accumulation and necrosis in multiple organs. The disease is characterised by fever, inappetence, 
ocular and nasal discharge, lesions of the buccal cavity and muzzle, diarrhoea and depression. Cattle 
may survive for a week or more after the appearance of the first clinical signs, while bison and deer 
generally die after a few days. Currently there is no treatment or vaccine commercially available for 
MCF. 
AlHV-1, unlike OvHV-2, is the only MCF virus that currently can be propagated in culture 
and has therefore been used as a model for the sheep-associated form of the disease.  The virus 
genome has been sequenced 
5
 and is very similar to the genome of OvHV-2 
6
. Small animal models of 
AlHV-1 infection are available and have been characterised 
7, 8
. Extended passage of pathogenic 
AlHV-1 leads to attenuation 
9
 and this is associated with rearrangements within the virus genome 
10
.  
Attenuated AlHV-1 has recently been shown to protect cattle from fatal challenge with pathogenic 
virus and therefore represents a candidate vaccine for MCF 
11, 12
.  The attenuated and pathogenic 
AlHV-1 strains have recently been characterised by proteomic methods, demonstrating that there are 
few major differences between the strains 
13
.  
As part of our studies to understand the basis of MCF pathology in cattle we have been 
studying the antigenic capsid proteins of AlHV-1
14
.  However, interactions between the virus and host 
are also likely to be influenced by the membrane glycoproteins of the virus, which are responsible for 
interactions with cell surface receptors on target cell types and fusion of virus and cell membranes. 
The gp115 glycoprotein complex of AlHV-1 was defined by immunoprecipitation with monoclonal 
antibody (mAb) 12B5 
15
 and mAb 152-A 
16
 as having components of approximately 115, 110, 105, 78 
and 48 kDa. Further analysis demonstrated that this complex appeared to be composed of a single 
polypeptide that was glycosylated to generate the mature 115 kDa form, which was then cleaved to 
produce a covalently-linked complex comprising 78 kDa and 48 kDa chains in the virus particle 
15
. 
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Recent proteomic analysis of polyacrylamide gel fractionated AlHV-1 virus proteins 
13
 showed that 
glycoprotein B (gB) was found in two bands with relative mobility estimated at 80 kDa and 50 kDa, 
respectively. Examination of the gB peptides identified in the two bands showed that the 80 kDa band 
contained N-terminal peptides and the 50kDa band contained C-terminal peptides, relative to the 
position of a furin cleavage site 
13
. The existing published data therefore support the hypothesis that 
mAb 12B5 recognises an epitope on gB and that the 78 kDA and 48 kDa bands identified previously 
are the furin cleaved N- and C-terminal fragments of gB.  
The aims of this work were to confirm the interaction of mAb 12B5 with AlHV-1 gB by 
expression of a recombinant, epitope tagged polypeptide and to characterise the expression and 
antigenicity of the recombinant gB polypeptide. 
 
Materials and methods 
Cells and virus 
AlHV-1 C500 strain was propagated in bovine turbinate (BT) cells grown in Iscove’s Modified 
Dulbecco’s Medium (IMDM; Life Technologies, Paisley, UK), with 5 % foetal bovine serum (FBS) 
and 2 % L-glutamine. BT cells were infected with pathogenic AlHV-1 C500 at a multiplicity of 
infection (MOI) of 3 and virus-infected cells were harvested after 3-5 days. Cell-associated virus 
particles were isolated after three rounds of freeze-thaw treatment, clarified by centrifugation and 
stored in batches at -80 °C until required. Representative aliquots of virus were titrated as described 
previously 
11
. 
Human embryonic kidney 293T (HEK293T) cells were used for transfection studies following 
previous experiments that had shown that this cell line provided both a high frequency of transfection 
and a high level of expression of  MCF virus genes 
17, 18
. For transfection and subsequent protein 
expression, cells were grown in IMDM with 10 % FBS and 2 % L-glutamine. For fluorescence 
microscopy, sterile coverslips were first treated with 500 µl of poly-L- lysine for 20 minutes to 
improve cell adherence. Excess poly-L-lysine was removed and the coverslips were dried in a 37˚C 
incubator for 1 hour. Cells were seeded onto coverslips at 2x10
5
 per well of a 24 well dish in IMDM 
before transfection. After 6 hours at 37 °C, 5 % CO2 the medium was changed to serum-free Opti-
MEM (Life Technologies).  
 
Amplification and cloning of the gB gene 
The gene encoding gB (ORF8 
5
) from AlHV-1 was expressed in recombinant form as follows: ORF8 
was amplified from AlHV-1 strain C500 DNA by PCR using primers ORF8FwdAsc (5’-GGC GCG 
CCG GCG CAC ACA GGT AGC ACA GTC T-3’), ORF8RevFse (5’-GGC CGG CCC GAC ACC 
AGT GCT CTC AAA AGA GT-3’) and KOD hot-start DNA polymerase (Merck, Nottingham, UK).  
The 2.6 kbp fragment was inserted into pCR4-blunt-TOPO (Life Technologies) and the DNA 
sequence of the resulting clones was determined using flanking and internal primers.  A verified 
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ORF8 fragment was excised using restriction enzymes AscI and NgoMIV and inserted into the 
mammalian expression vector pVR-MCS-HA, derived from pVR1255 (a kind gift from Vical Inc. 
19
).  
To generate pVR-MCS-HA, a synthetic 218 bp double-stranded cassette encoding a ribosome binding 
site with start codon, a multiple cloning site, a TEV protease cleavage site and a C-terminal triple-HA 
(haemagglutinin) epitope tag (TOP Gene Technologies, Montreal Canada; accession number 
FN553440) was inserted between the NotI and BamHI sites of pVR1255. The correct structure of the 
resulting AlHV-1 gB expression vector (pVR-ORF8-HA) was confirmed by restriction enzyme 
analysis. 
 
Antibodies  
Monoclonal antibody 12B5 was raised against whole AlHV-1 virus antigen in BALB/c mice and was 
shown to be specific for the virus major glycoprotein complex in western blots and 
immunoprecipitation experiments
15
. For western blotting of HA-tagged proteins, a directly conjugated 
rat monoclonal anti-HA-peroxidase high affinity (3F10; Roche) was used. Secondary antibodies used 
for western blotting were HRP-conjugated polyclonal goat-anti-mouse immunoglobulins (Dako , 
Glostrup, Denmark) and polyclonal rabbit-anti-bovine IgG-HRP (Sigma). For flow cytometry and 
fluorescence microscopy, the following antibodies were used: mouse anti-HA IgG3 (Abcam); Alexa 
488-conjugated goat-anti-mouse IgG3 (Life Technologies); mouse anti-tubulin IgG1 (Abcam); Alexa 
555-conjugated goat-anti-mouse IgG1 (Life Technologies). 
 
Transfection 
Briefly, HEK293T cells were grown in IMDM containing 5 % FBS and 2 mM L-glutamine, to 70 % 
confluence before being transfected with plasmid DNA (1µg per 10
6
 cells) using Lipofectamine 2000 
(Life Technologies) according to the manufacturer’s protocol. The transfection reagent was replaced 
with fresh medium after four hours and transfected cells were allowed to grow for up to 72 h before 
harvesting cells and medium. 
Protein extracts for western blotting and ELISA were made 48h post-transfection by lysing single-cell 
suspensions in 0.8 % CHAPS (3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate) in 
Tris-buffered saline pH 8.3.  
 
Electrophoresis and western blotting 
Protein extracts (approx. 10 µg per lane) were fractionated in denaturing, reducing 10 % NuPAGE® 
Bis-Tris gels (Life Technologies).  Protein bands were visualised with SimplyBlue SafeStain (Life 
Technologies) or transferred to nitrocellulose using the X-cell II semi-wet Blot module in 1× 
NuPAGE Transfer buffer (Life Technologies) containing 10 % or 20 % methanol, following 
manufacturer’s guidelines. Nitrocellulose membranes were blocked in in PBST [1×PBS, 0.05 % (v/v) 
TWEEN20 (Sigma)] containing 5 % non-fat milk powder (5 % milk), then washed several times in 
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PBST. For HA- tag detection, proteins were probed with anti-HA-HRP according to the 
manufacturer’s instructions. Detection of gB with monoclonal antibody 12B5 was done with 1:1000 
dilution of affinity-purified 12B5 followed by incubation with HRP-conjugated goat-anti-mouse Ig. 
For detection by antibodies from MCF vaccinated or infected animals, blood serum or plasma was 
diluted 1:100 in PBST containing 5 % milk. Bound antibodies were detected with polyclonal rabbit-
anti-cow immunoglobulin-HRP. Finally, blots were washed several times with PBST then incubated 
for 5 min in SuperSignal West Pico Chemiluminescent Substrate (Pierce) before visualisation of 
bands using the ImageQuant LAS4000 imaging system (GE Healthcare). 
 
Proteomic analysis 
The identification of recombinant AlHV-1 gB fractionated by gel electrophoresis was done by liquid 
chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) as described 
previously 
13,
 
14
. Briefly, protein bands excised from PAGE gels were subjected to standard in-gel 
destaining, reduction, alkylation and trypsinolysis, followed by liquid chromatography interfaced with 
a 3-D high capacity ion trap mass spectrometer (Esquire HCTplusTM, Bruker Daltonics). Mass 
spectral data were analysed using the Mascot V2.2 (Matrix Science) search algorithm against viral 
and mammalian subsections of the NCBI non-redundant protein sequence databases. Protein 
identification within a gel band required a minimum of two peptides to be matched, with each peptide 
containing an unbroken ‘‘b’’ or ‘‘y’’ ion series of at least four amino acid residues. 
 
ELISA 
Extracts of transfected or untransfected HEK293T cells  were prepared as described above and serial 
dilutions (in 0.1M carbonate buffer pH9.6) were used to coat triplicate wells of 96-well microtitre 
plates (Greiner, high binding). After washing in PBST, detection of the MCF antigen was assayed 
using a 1:200 dilution of an AlHV-1-positive plasma pool that had previously been used as a control 
in analysis of vaccinated cattle 
12
. Antibody bound in each well was detected using 1:1000 rabbit anti-
bovine IgG-Horseradish Peroxidase conjugate (Sigma) and colourimetric detection using 
Tetramethylbenzidine (TMB; Sigma). Average optical density at 450nm was used as the measure of 
ELISA response. 
 
Flow cytometry 
BT cells were infected with pathogenic AlHV-1 C500 at MOI = 3. After 24h, the infected cells were 
harvested and stained with mAb 12B5 or isotype-matched control antibody (VPM21 
20
), followed by 
phycoerythrin-conjugated anti-mouse IgG1 secondary antibody. After staining, the cells were washed 
twice in FACS buffer and fixed in PBS/0.02 % sodium azide before storing dark and on ice. 
Samples were acquired using a FACSCalibur instrument (Becton Dickinson, NJ, USA) equipped with 
488 nm argon-ion and 635 nm red diode lasers and CellQuest software. Forward (FSC) and side 
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scatter (SSC) were collected as linear signals, and fluorescent emissions were collected on a four-
decade logarithmic scale. A bandpass filter for phycoerythrin was employed to collect the signal in 
fluorescence channel 2 (FL2, 585 ± 21 nm). A minimum of 10,000 cells were acquired for each 
sample by gating lymphoid (monocyte/lymphocyte) cells on forward and side scatter. 
 
Fluorescence microscopy 
Cells for fluorescence microscopy were incubated for 48 hours after transfection or seeding onto 
coverslips before fixing with 4 % paraformaldehyde (Sigma) in PBS at room temperature for 1 hour. 
Cells were washed twice with PBS and once with immunofluoresence buffer (IFF; 2 % FBS, 1 % 
BSA in PBS). Cells were stored at 4 °C in IFF.  
Fixed cells were permeabilised using 0.5 % triton-X-100 in PBS for 10 minutes at room temperature.  
Cells were then rinsed twice with PBS and once with IFF. Cells were incubated in primary antibody 
diluted in IFF for 40 minutes at room temperature. Cells were then washed twice with PBS and once 
with IFF before incubation in the appropriate secondary antibody diluted in IFF for 40 minutes in the 
dark at room temperature. Cells were washed three times with PBS, refixed with 4 % PFA for 20 
minutes, and then rinsed three times with PBS, with the final wash containing DAPI. The cells were 
rinsed with water and mounted onto slides with Vectashield (Vector Labs) and sealed with clear nail 
varnish. 
Stained cells were visualised using a motorised Zeiss axiovert 200M inverted epifluorescence 
microscope with apotome and an axiocam MR3 camera. The following Zeiss filter sets were used; set 
38H (excitation BP470/40, Beam splitter FT495, Emission BP525/50) set 43 (excitation BP 545/25, 
Beam splitter FT 570, emission BP 605/70), set 49  (excitation G 365, Beam splitter FT395, Emission 
BP 445/50) and set 50 (excitation BP640/30, Beam splitter FT 660, emission BP 690/50). Image 
analysis was undertaken using Zeiss axiovision software.  
 
Results  
Expression of AlHV-1 gB 
To address the hypothesis that mAb 12B5 recognised an epitope on AlHV-1 glycoprotein B, the 
AlHV-1 ORF8 gene, encoding gB, was cloned into a haemagglutinin (HA)-tagged expression vector 
based on pVR1255 
19
. The resulting construct, pVR-ORF8-HA, was transfected into HEK293T cells 
and protein extracts were made 48h post-transfection. A western blot of whole-cell extracts probed 
with anti-HA-HRP conjugate showed that AlHV-1 gB was detected as three bands with apparent Mr 
of  approximately 100 kDa, 50 kDa and 20 kDa (Fig. 1A). These bands presumably corresponded to 
full-length gB and two cleaved forms carrying the C-terminal HA-tag.  An equivalent gel, carrying 
extracts of HEK293T cells expressing gB and BT cells infected with pathogenic AlHV-1 virus, was 
blotted using mAb 12B5. This showed that whilst a single major band with Mr of about 70 kDa was 
recognised in the virus extract by 12B5, three bands were recognised within the recombinant gB 
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extract with approximate Mr of 100 kDa, 70 kDa and 60 kDa (Fig. 1B).  This confirmed that mAb 
12B5 recognised gB and suggested that the HA-tagged 50 kDa and 20 kDa cleaved products of gB 
seen in Fig. 1A had lost the 12B5 epitope. The differences in bands recognised by mAb 12B5 between 
the virus preparation and the gB-transfected cell extract (Fig. 1B) likely reflect differences in post-
translational processing between the two cell lines, including both glycosylation and furin cleavage. 
While gB in the mature AlHV-1 virion appeared to be almost fully cleaved by furin, with only a faint 
band at the uncleaved ~100 kDa position, the recombinant protein expressed in HEK293T cells was 
mostly uncleaved, with a smaller proportion of the gB appearing as bands with lower Mr. This is in 
accord with observations in other gammaherpesviruses that cleavage of gB is closely associated with 
virion assembly 
21
. The detection of two 12B5-detected bands with mobility 60-80 kDa in the 
recombinant gB lane (Fig. 1B) is in keeping with previous observations that furin cleavage of the 115 
kDa and 110 kDa components of the major envelope glycoprotein complex in infected cells gave rise 
to bands with Mr 78 kDa and 66 kDa respectively 
15
.  This supports the published evidence that 
HEK293T cells express furin 
22
 and suggests that limited furin cleavage of recombinant gB can occur 
in the absence of virion assembly. Thus, recombinant gB expressed in HEK293T cells appears to be 
subject to both incomplete post translational modification and additional proteolytic cleavage to 
produce the lower bands observed in Fig. 1A and 1B. Attempts to express recombinant gB in AlHV-1 
infected cells have been unsuccessful to date.  This may reflect the poor levels of transfection 
achievable in the AlHV-1 permissive cell lines tested or the silencing of the recombinant gB construct 
in AlHV-1 infected cells. 
Proteomic analysis of gB fragments 
To further confirm the identity of the HA-tagged 50 kDa and 20 kDa bands (Fig. 1A), they 
were subject to proteomic analysis following excision of the bands from SDS-PAGE of affinity-
purified recombinant gB. MS/MS analysis did not provide any evidence of gB-specific peptides in the 
20 kDa band but the 50 kDa band yielded multiple gB-specific peptides that were mainly C-terminal 
of position 300 (Online Resource 1). These observations suggest that recombinant gB may be cleaved 
at sites on both sides of the furin cleavage site in addition to any furin cleavage that occurs. These 
data also suggest that the mAb 12B5 epitope is likely to be N-terminal of position 300. 
The absence of detectable gB-specific peptides in the 20 kDa HA-tagged band may reflect a 
lack of suitable peptides for mass spectrometry in the C-terminal portion of the protein. This fragment 
is likely to include the transmembrane and cytoplasmic regions of gB and the triple-HA tag, which 
may influence the ionisation or detection of gB peptides. This is supported by the lack of sequenced 
peptides from the C-terminal region (residues 700-860) of the 50kDa gB-HA fragment and the low 
abundance of mass-matched peptides (Online Resource 1).  
Detection of recombinant gB by sera from infected animals 
To further study the antigenic properties of AlHV-1 gB, we analysed the reactivity of affinity-
purified recombinant gB in western blots with antibodies from: naturally infected wildebeest, from 
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cattle MCF cases induced by AlHV-1 or OvHV-2 and from cattle immunised with the attenuated 
AlHV-1 vaccine 
11
 (Fig. 2A). This demonstrated that all three recombinant gB bands were recognised 
by antibodies from both immunised and MCF-affected animals and showed cross-reactivity between 
AlHV-1 gB and OvHV-2-specific serum. These observations were confirmed by ELISA analysis of 
extracts of HEK293T cells transfected with pVR-ORF8-HA using an AlHV-1-positive antibody pool. 
This showed that MCF-specific antibodies could detect gB at dilutions down to at least 1/200 (0.05) 
of a crude extract of transfected HEK293T cells, whilst an equivalent extract containing a non-
antigenic HA-tagged recombinant protein (ORF25 
14
) was not significantly different from an extract 
of untransfected HEK293T cells (Fig. 2B). 
Detection of gB expression by flow cytometry and fluorescence microscopy 
Having confirmed that mAb 12B5 recognised recombinant and native glycoprotein B in 
western blots and ELISA, we then tested whether it could detect expression of gB on the surface of 
productively-infected cells. BT cells were infected with pathogenic AlHV-1, harvested after 24h and 
stained with mAb 12B5 for analysis by flow cytometry (FACS). About 10 % of the BT cells 
expressed the 12B5 epitope (Fig. 3), showing that mAb 12B5 could recognise the gB antigen in its 
native conformation and that gB was expressed on the surface of infected cells within 24h. 
The sub-cellular localisation of recombinant gB in transfected HEK293T cells was also 
confirmed by fluorescence microscopy (Online Resource 2). Staining with anti-HA showed that gB in 
transfected cells was detected mainly at the cell surface, and that this localisation could be inhibited 
by treatment of the cells with Brefeldin A, which inhibits intracellular transport (data not shown).  
 
 
Discussion 
These studies have shown for the first time that the polypeptide which forms the gp115 
glycoprotein complex of AlHV-1, identified on infected cells as five bands with Mr 115-48 kDa 
15, 16
, 
is glycoprotein B, which is post-translationally modified and cleaved by furin during assembly into 
virus particles.  The observation that recombinant gB, expressed in HEK293T cells, is poorly cleaved 
by furin and appears to be susceptible to degradation by other proteases, suggests that virus assembly 
may be an essential part of the correct processing of gB.  This is in accord with the known properties 
of gB in other herpesviruses where association of gB with the gH/gL glycoprotein pair constitutes the 
core fusion machinery, while additional viral glycoprotein components of the fusion complex may act 
as cell-type-specific receptors 
23
. It is notable that a recombinant OvHV-2 gB fusion polypeptide 
expressed in transfected cells was also subject to proteolysis, revealing bands of about 110 and 50 
kDa 
24
 when blotted with an epitope tag antibody. Recombinant gB (in addition to other MCF virus 
antigenic proteins 
14, 24
) has been suggested as a good candidate for a recombinant vaccine for MCF 
and the observation that AlHV-1 gB is recognized by OvHV-2-specific antiserum suggests that cross-
protection might occur. 
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Immunisation of rabbits with OvHV-2 gB induced antibodies that reduced the infectivity of 
OvHV-2 in an in vivo assay 
24
. As gB is a known target for herpesvirus neutralization 
25
, and because 
mAbs now known to be specific for AlHV-1 gB have been shown to have virus neutralizing activity 
15, 16
, it will be of interest to determine whether recombinant AlHV-1 gB can induce virus neutralizing 
antibodies and protect immunized animals from malignant catarrhal fever. This work is currently 
ongoing. 
The data presented here confirm the gB specificity of mAb 12B5 
15
 and suggests that other 
mAbs with specificity for the gp115 complex of AlHV-1 are also likely to recognize epitopes on gB 
15,16
. Notably, the mAb 152A described by Li and colleagues 
16
 recognized a polypeptide with Mr ~ 45 
kDa under denaturing conditions. It is now likely that the epitope recognized by this mAb is on the C-
terminal furin cleaved fragment of gB.    
Previous studies and work here have demonstrated that mAb 12B5 is virus neutralizing and 
can detect gB by immunoprecipitation, by ELISA, in western blots, flow cytometry and fluorescence 
microscopy. Attempts to visualize gB expression by immunohistochemistry of fixed tissue sections 
from MCF affected cattle and rabbits have been unsuccessful to date (data not shown), suggesting that 
mAb 12B5 is not suitable for this application or that gB is not expressed in MCF-affected tissues. 
However this versatile reagent has considerable potential for use in diagnostic applications, for 
analysis of the AlHV-1 fusion machinery and for analysis of glycoprotein expression in AlHV-1 
infection and MCF. 
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Figure Legends 
 
Fig. 1 mAb 12B5 recognizes AlHV-1 glycoprotein B.  (A) Western blotting with anti-HA antibody 
detected three HA-tagged bands in a detergent extract of HEK293T cells transfected with pVR-ORF8-
HA (gB).  (B) Western blotting with mAb 12B5 detected three bands in HEK293T cells transfected 
with pVR-ORF8-HA  (gB), but detected one major band in cell-associated AlHV-1 C500 virus (V).   
Pre-stained protein size markers (M; SeeBlue® Plus2, Life Technologies) were imaged in parallel and 
a merged monochrome image is presented. Marker sizes are indicated on the left of each panel 
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Fig. 2 Detection of recombinant AlHV-1 gB by MCF-positive antibodies using western blotting and 
ELISA. (A) Western blots of recombinant gB extracts probed with serum or plasma from: an AlHV-1 
infected wildebeest (lane 1); a cow with AlHV-1-induced MCF (lane 2); a cow vaccinated with 
attenuated AlHV-1 (lane 3); a cow with OvHV-2-induced MCF (lane 4); and a MCF-negative control 
cow (lane 5), was used to detect recombinant gB fractionated by denaturing, reducing SDS-PAGE.  
Antibody binding was detected as described in Fig 1. Pre-stained protein size markers (M; SeeBlue® 
Plus2, Life Technologies) were imaged in parallel and a merged monochrome image is presented. 
Marker sizes are indicated on the left of the figure. (B)  ELISA analysis of recombinant gB. Serial 
dilutions of detergent extracts of HEK293T cells (filled triangles) and the same cells transfected with 
pVR-ORF8-HA (filled circles; expressing AlHV-1 gB) or pVR-ORF25-HA (filled squares; 
expressing HA-tagged AlHV-1 major capsid protein) were coated on ELISA plates and their specific 
reactivity was tested using 1/200 dilution of pooled MCF-positive plasma Mean optical density (OD) 
values are plotted against extract dilution 
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Fig. 3  Flow cytometric analysis of mAb 12B5 binding to infected cells.  Bovine turbinate (BT) cells 
were infected with pathogenic AlHV-1, harvested after 24h, stained with an isotype-matched control 
antibody (left panel) or mAb 12B5 (right panel) and phycoerythrin-conjugated anti-mouse IgG1 
secondary antibody for analysis by flow cytometry (FACS) Phycoerythrin fluorescence (FL2H) was 
plotted against cell size/complexity (FSC-H) and demonstrated that about 10 % of BT cells expressed 
gB 24h after infection as detected by 12B5, while less than 1 % of cells were stained by the isotype 
control antibody (gated region R4 in each panel) 
 
Figure 3 
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Online Resource 1  
Proteomic analysis of 50 kDa HA-tagged band of recombinant expressed AlHV-1 gB  
A. Graphical representation of peptide detection by MALDI-MS (grey bars represent peptides with 
masses that closely match peaks in the MS spectrum; darker bars are more abundant peptides) and 
amino acid sequences inferred from MALDI-MS/MS secondary fragmentation of abundant peptides 
(red blocks). Each red block represents a b- or y-ion mass matched to the amino acid residue at that 
position. An unbroken b or y ion series comprising a minimum of four amino acid residues is 
considered good evidence for peptide identification. The recognition site for furin cleavage (RRQRR) 
is boxed and predicted N-linked glycosylation sites are highlighted in yellow.  
 
 
 
B. Chart of peptide intensity, derived from MALDI-MS analysis of the 50 kDa band of gB. Peptide 
peak intensities, derived from the raw mass-spectral data, are plotted as bars at the appropriate 
positions along the length of the AlHV-1 gB polypeptide sequence. Any peptide with MS/MS 
evidence of its presence (according to the criteria set out in Figure S1A, above) is indicated by an 
asterisk (*) above the column and the position of the furin cleavage site is indicated by an arrow.  
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Online Resource 2.  
Immunofluorescence localization of AlHV-1 gB in transiently transfected HEK293T cells.  
A: nuclei stained with the DNA–specific stain DAPI (blue);  
B: gB-HA stained with mouse anti-HA IgG3 and Alexa 488-conjugated goat-anti-mouse IgG3 
(green); and  
C: α-tubulin stained with mouse anti-tubulin IgG1 and Alexa 555-conjugated goat-anti-
mouse IgG1 (Life Technologies) (red).  
D: false-colour image combining the signals from A-C.  
Scale bar in panel A represents 20 µm. 
 
 
